The broad tuberculosis vaccine treatment market has been sub-grouped into type of test, type of tuberculosis vaccine and end-user. the geographical segmentation, which mainly focuses on current and forecast demand for tuberculosis vaccine treatment in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
By Type Of Test
- Tuberculin Skin Test
- TB Blood Test
- Interferon-Gamma Release Assays
By Type Of TB Vaccine
- Immunotherapeutic Vaccine
- Booster Vaccine
By End-User
- Hospital
- Private Clinics
- Research Institutes
The rapid proliferation of tuberculosis among the population has generated high demand for tuberculosis vaccines treatment. Favorable initiatives and awareness campaign was taken by various governments to reduce the prevalence of tuberculosis are further fueling the market growth. Also, improving healthcare infrastructure coupled with a rising inclination towards prevention of disease over cure is further boosting the market growth. Growing demand for advanced TB vaccines owing to rising cases of drug-resistant TB infection is further pushing the market growth uphill.
The key players in the tuberculosis vaccine treatment market include GlaxoSmithKline Plc, GreenSignal Bio Pharma Limited, IDT Biologics GmbH, Merck & Co., Inc., Sanofi Pasteur SA, Serum Institute Of India Pvt. Ltd and Taj Pharmaceuticals Limited among others.
Source: https://www.valuemarketresearch.com/report/tuberculosis-vaccine-treatment-market
Naira Shekhawat has been into Content Writing just after completing her Graduation in English Literature. Her love for words has won her many accolades in her respective jobs ever since. Naira covers business sections for VMR News. She is a traveller by heart and loves writing on food blogs as a freelancer.